Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
ERK Pathway
100%
Circular RNA
100%
Lung Cancer
80%
Tumor Growth in Vivo
40%
Poor Prognosis
20%
Knockdown
20%
Clinical Samples
20%
Phosphorylation
20%
ERK2
20%
Non-coding RNA (ncRNA)
20%
Putative Drug Targets
20%
Therapeutic Target
20%
Prognostic Biomarker
20%
Non-small Cell Lung Carcinoma Cells
20%
TargetScan
20%
EGFR-MAPK
20%
Immunoblotting
20%
Cancer Causes
20%
Cancer Mortality
20%
RNA Sequencing (RNA-seq)
20%
Cyclin-dependent Kinase 6 (CDK6)
20%
EGFR Pathway
20%
P70S6K
20%
Xenograft Tumor Growth
20%
MiR-142-5p
20%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
20%
Cyclin-dependent Kinase 1 (CDK1)
20%
Stable Overexpression
20%
MAPK-ERK Signaling
20%
Early-stage Lung Cancer
20%
Circ_0000190
20%
Global Translation
20%
Transient Overexpression
20%
CRISPR-Cas13a
20%
Medicine and Dentistry
Lung Cancer
100%
Non Small Cell Lung Cancer
100%
Epidermal Growth Factor Receptor
100%
In Vitro
33%
Tumor Progression
33%
Cyclin-Dependent Kinase
33%
Cell Line
16%
RNA Sequence
16%
Malignant Neoplasm
16%
Biological Marker
16%
Carcinoma Cell
16%
Xenograft
16%
Kinase
16%
Mitogen-Activated Protein Kinase
16%
Untranslated RNA
16%
Cell Cycle
16%
Clustered Regularly Interspaced Short Palindromic Repeat
16%
Mitogen Activated Protein Kinase 3
16%
Immunoblotting
16%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Non Small Cell Lung Cancer
100%
Epidermal Growth Factor Receptor
100%
Tumor Growth
33%
RNA-Sequencing
16%
Malignant Neoplasm
16%
Western Blot
16%
Mitogen Activated Protein Kinase 3
16%
Biological Marker
16%
Untranslated RNA
16%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Tumor Progression
50%
Cyclin-Dependent Kinase
50%
Cell Cycle
25%
Non-Coding RNA
25%
Mitogen-Activated Protein Kinase
25%
RNA Sequence
25%
CRISPR
25%
Immunoblotting
25%